Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Tina Lorenson"'
Autor:
Kirstin Krudwig, Robert Steinglass, Alexis Heaton, Tina Lorenson, Andrew Cunningham, Craig Burgess
Publikováno v:
Vaccine. 35:2272-2278
The widespread use of multidose vaccine containers in low and middle income countries’ immunization programs is assumed to have multiple benefits and efficiencies for health systems, yet the broader impacts on immunization coverage, costs, and safe
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ab17b48b679221c30618cd96caab1b90
https://doi.org/10.1016/j.vaccine.2016.11.066
https://doi.org/10.1016/j.vaccine.2016.11.066
Publikováno v:
Vaccine
Highlights • Interviews (158) conducted with immunization personnel in 6 countries. • Respondents are interested in vaccines with improved heat and freeze stability. • Most involved in vaccine purchases would pay a slight premium for those feat
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::beeb1406b307b31b17e3c87d4f5e3dee
https://doi.org/10.1016/j.vaccine.2016.01.001
https://doi.org/10.1016/j.vaccine.2016.01.001
Autor:
Nicholas, Luter, Ritu, Kumar, Dai, Hozumi, Tina, Lorenson, Shannon, Larsen, Bhavya, Gowda, Amie, Batson
Publikováno v:
Vaccine
Highlights • 8 factors predict the viability of vaccine manufacturers in developing countries. • These factors have evolved as the vaccine landscape has changed over 2 decades. • A new analysis updates a framework first published in 1997 to ass
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::041a1d3f849ac481a24a2d2a92c29953
https://pubmed.ncbi.nlm.nih.gov/28602604
https://pubmed.ncbi.nlm.nih.gov/28602604
Publikováno v:
BMC Medicine. 9/15/2016, Vol. 14, p1-7. 7p. 2 Charts.
Autor:
Lal, M., Zhu, C., McClurkan, C., Koelle, D. M., Miller, P., Afonso, C., Donadeu, M., Dungu, B., Chen, D.
Publikováno v:
Veterinary Record: Journal of the British Veterinary Association; 5/17/2014, Vol. 174 Issue 21, following p504-504, 7p
Publikováno v:
Health Policy & Planning; May2012 Supplement 2, Vol. 27 Issue suppl_2, pii17-ii26, 1p
Autor:
John A. Quelch
The public health footprint associated with corporate behavior has come under increased scrutiny in the last decade, with an increased expectation that private profit not come at the expense of consumer welfare. Consumers, Corporations, and Public He
Autor:
John A. Quelch, Margaret Rodriguez
In February 2014, Michael Schrader, chief executive of Vaxess Technologies, Inc., was assessing the startup health care company's 2014 marketing plan. On December 31st, 2013, Vaxess had obtained an exclusive license to a series of patents for a silk